Type IV collagenases in invasive tumors
- 80 Downloads
The matrix metalloproteinases appear to be elevated in tumors with metastatic potential, and may well be involved in penetration of the basement membrane and degradation of extracellular proteins including type IV collagen. An imbalance between the 72 kDa and 92 kDa type IV collagenases and the associated tissue inhibitors of these metalloproteinases (TIMPs) may therefore have a role in the invasive phenotype. Cultured tumor cells with invasive potential secrete both type IV collagenases, though in tumors there is some evidence that the 72 kDa form at least may be produced by stromal cells at the invading tumor front rather than primarily by the tumor cells themselves, while the 92 kDa form may be synthesized in macrophages near the front. These collagenases are elevated in invasive as compared within situ tumor components, but their specific roles and prognostic significance are not yet established.
Key wordsextracellular matrix invasion metalloproteinases TIMPs type IV collagenases
Unable to display preview. Download preview PDF.
- 4.Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He C, Bauer EA, Goldberg GI: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263:6579–6587, 1988PubMedGoogle Scholar
- 14.Whitham SE, Murphy G, Angel P, Rahmsdorf H-J, Smith BJ, Lyons A, Harris T, Reynolds JJ, Herrlich P, Docherty AJP: Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J 240:913–916, 1987Google Scholar
- 18.Quantin B, Murphy G, Breathnach R: Pump-1 codes for a protein with characteristics similar to those of classical collagenase family members. Biochem 28:5327–5334, 1989Google Scholar
- 20.Fridmen R, Fuerst TR, Bird RE, Höyhtyä M, Oelkuct M, Kraus S, Komarek D, Liotta LA, Berman ML, Stetler-Stevenson WG: Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J Biol Chem 267:15398–15405, 1992PubMedGoogle Scholar
- 40.Autio-Harmaninen H, Karttunen T, Hurskainen T, Höyhtä M, Kauppila A, Tryggvason K: Expression of 72 kDa type IV collagenase in benign and malignant ovarian tumors. SubmittedGoogle Scholar
- 42.Ura H, Bonfil RD, Reich R, Reddel R, Pfeifer A, Harris CC, Klein-Szanto AJP: Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res 49:4615–4621, 1989PubMedGoogle Scholar
- 46.Pyke C, Ralfkiaer E, Tryggvason K, Danø K: Messenger RNA for two type IV collagenases is located in nonmalignant stromal cells in human colon cancer. Am J Pathol, in press.Google Scholar